3-160366130-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_020800.3(IFT80):​c.462G>A​(p.Ala154Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0194 in 1,610,788 control chromosomes in the GnomAD database, including 404 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A154A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.023 ( 58 hom., cov: 32)
Exomes 𝑓: 0.019 ( 346 hom. )

Consequence

IFT80
NM_020800.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.08

Publications

3 publications found
Variant links:
Genes affected
IFT80 (HGNC:29262): (intraflagellar transport 80) The protein encoded by this gene is part of the intraflagellar transport complex B and is necessary for the function of motile and sensory cilia. Defects in this gene are a cause of asphyxiating thoracic dystrophy 2 (ATD2). Three transcript variants encoding two different isoforms have been found for this gene.[provided by RefSeq, Jun 2010]
TRIM59-IFT80 (HGNC:56756): (TRIM59-IFT80 readthrough (NMD candidate)) This locus represents naturally occurring readthrough transcription between the neighboring TRIM59 (tripartite motif containing 59) and IFT80 (intraflagellar transport 80) genes on chromosome 3. The readthrough transcript is unlikely to produce a protein product. [provided by RefSeq, Jun 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 3-160366130-C-T is Benign according to our data. Variant chr3-160366130-C-T is described in ClinVar as [Benign]. Clinvar id is 343980.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.08 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0229 (3457/151018) while in subpopulation AFR AF = 0.0363 (1492/41114). AF 95% confidence interval is 0.0348. There are 58 homozygotes in GnomAd4. There are 1652 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 58 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IFT80NM_020800.3 linkc.462G>A p.Ala154Ala synonymous_variant Exon 6 of 20 ENST00000326448.12 NP_065851.1 Q9P2H3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IFT80ENST00000326448.12 linkc.462G>A p.Ala154Ala synonymous_variant Exon 6 of 20 1 NM_020800.3 ENSP00000312778.7 Q9P2H3-1
TRIM59-IFT80ENST00000483754.1 linkn.975G>A non_coding_transcript_exon_variant Exon 4 of 19 2 ENSP00000456272.1 H3BRJ5

Frequencies

GnomAD3 genomes
AF:
0.0229
AC:
3452
AN:
150902
Hom.:
58
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0364
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0228
Gnomad ASJ
AF:
0.0337
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00501
Gnomad FIN
AF:
0.00367
Gnomad MID
AF:
0.0192
Gnomad NFE
AF:
0.0203
Gnomad OTH
AF:
0.0214
GnomAD2 exomes
AF:
0.0165
AC:
4149
AN:
250950
AF XY:
0.0161
show subpopulations
Gnomad AFR exome
AF:
0.0403
Gnomad AMR exome
AF:
0.0106
Gnomad ASJ exome
AF:
0.0389
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00481
Gnomad NFE exome
AF:
0.0203
Gnomad OTH exome
AF:
0.0207
GnomAD4 exome
AF:
0.0191
AC:
27847
AN:
1459770
Hom.:
346
Cov.:
31
AF XY:
0.0189
AC XY:
13710
AN XY:
726280
show subpopulations
African (AFR)
AF:
0.0372
AC:
1241
AN:
33400
American (AMR)
AF:
0.0121
AC:
542
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0365
AC:
951
AN:
26070
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39656
South Asian (SAS)
AF:
0.00713
AC:
615
AN:
86206
European-Finnish (FIN)
AF:
0.00564
AC:
301
AN:
53400
Middle Eastern (MID)
AF:
0.0456
AC:
259
AN:
5678
European-Non Finnish (NFE)
AF:
0.0205
AC:
22752
AN:
1110372
Other (OTH)
AF:
0.0196
AC:
1182
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1264
2528
3791
5055
6319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0229
AC:
3457
AN:
151018
Hom.:
58
Cov.:
32
AF XY:
0.0224
AC XY:
1652
AN XY:
73696
show subpopulations
African (AFR)
AF:
0.0363
AC:
1492
AN:
41114
American (AMR)
AF:
0.0228
AC:
344
AN:
15088
Ashkenazi Jewish (ASJ)
AF:
0.0337
AC:
117
AN:
3468
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5150
South Asian (SAS)
AF:
0.00543
AC:
26
AN:
4788
European-Finnish (FIN)
AF:
0.00367
AC:
38
AN:
10364
Middle Eastern (MID)
AF:
0.0207
AC:
6
AN:
290
European-Non Finnish (NFE)
AF:
0.0203
AC:
1376
AN:
67770
Other (OTH)
AF:
0.0212
AC:
44
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
174
348
523
697
871
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0226
Hom.:
62
Bravo
AF:
0.0258
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.0223
EpiControl
AF:
0.0214

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Asphyxiating thoracic dystrophy 2 Benign:2
Aug 13, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jeune thoracic dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Connective tissue disorder Benign:1
May 12, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
1.0
DANN
Benign
0.59
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34182424; hg19: chr3-160083918; COSMIC: COSV58451288; API